Brief: Sight Sciences Q2 Revenue USD 21.4 Million Vs. IBES Estimate USD 21.3 Million
Aug 01 (Reuters) - Sight Sciences Q2 gross margin 86%. * Q2 gross profit USD 18.3 million * Q2 net income USD -12.3 million vs. IBES estimate USD -14.3 million * Q2 operating expenses USD 31 million
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights